Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 141

    1.

    Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study.

    Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ.

    J Psychiatr Res. 2013 Jun;47(6):706-11. doi: 10.1016/j.jpsychires.2013.02.005. Epub 2013 Mar 13.

    PMID:
    23490066
    [PubMed - in process]
    2.

    L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

    Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, Alpert JE, Barbee JG, Zisook S, Fava M.

    Am J Psychiatry. 2012 Dec 1;169(12):1267-74. doi: 10.1176/appi.ajp.2012.11071114.

    PMID:
    23212058
    [PubMed - indexed for MEDLINE]
    3.

    Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.

    Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M.

    CNS Spectr. 2012 Jun;17(2):76-86. doi: 10.1017/S1092852912000430.

    PMID:
    22789065
    [PubMed - indexed for MEDLINE]
    4.

    Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.

    Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GI.

    J Clin Psychiatry. 2012 Jun;73(6):843-8. doi: 10.4088/JCP.11m07139. Epub 2012 May 15.

    PMID:
    22687580
    [PubMed - indexed for MEDLINE]
    5.

    Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.

    Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI.

    J Affect Disord. 2012 Feb;136(3):1174-8. doi: 10.1016/j.jad.2011.04.059. Epub 2011 Sep 10.

    PMID:
    21911258
    [PubMed - indexed for MEDLINE]
    6.

    Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.

    Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI.

    Eur Psychiatry. 2012 Oct;27(7):518-21. doi: 10.1016/j.eurpsy.2011.03.006. Epub 2011 Jun 12.

    PMID:
    21665441
    [PubMed - indexed for MEDLINE]
    7.

    Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study.

    Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM.

    Am J Psychiatry. 2011 Jun;168(6):593-602. doi: 10.1176/appi.ajp.2010.10010032. Epub 2011 Mar 15.

    PMID:
    21406462
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    SAMe and sexual functioning.

    Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI.

    Eur Psychiatry. 2012 Aug;27(6):451-4. doi: 10.1016/j.eurpsy.2011.01.003. Epub 2011 Mar 12.

    PMID:
    21398094
    [PubMed - indexed for MEDLINE]
    9.

    An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers, and natural remedies.

    Huffman JC, Alpert JE.

    Med Clin North Am. 2010 Nov;94(6):1141-60, x. doi: 10.1016/j.mcna.2010.08.009. Review.

    PMID:
    20951275
    [PubMed - indexed for MEDLINE]
    10.

    S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.

    Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M.

    Am J Psychiatry. 2010 Aug;167(8):942-8. doi: 10.1176/appi.ajp.2009.09081198. Epub 2010 Jul 1.

    PMID:
    20595412
    [PubMed - indexed for MEDLINE]
    11.

    Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder.

    Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE.

    Psychosomatics. 2010 Mar-Apr;51(2):124-9. doi: 10.1176/appi.psy.51.2.124.

    PMID:
    20332287
    [PubMed - indexed for MEDLINE]
    12.

    Psychiatric OSCE performance of students with and without a previous core psychiatry clerkship.

    Goisman RM, Levin RM, Krupat E, Pelletier SR, Alpert JE.

    Acad Psychiatry. 2010 Mar-Apr;34(2):141-4. doi: 10.1176/appi.ap.34.2.141.

    PMID:
    20224028
    [PubMed - indexed for MEDLINE]
    13.

    Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

    Bhuvaneswar CG, Baldessarini RJ, Harsh VL, Alpert JE.

    CNS Drugs. 2009 Dec;23(12):1003-21. doi: 10.2165/11530020-000000000-00000. Review.

    PMID:
    19958039
    [PubMed - indexed for MEDLINE]
    14.

    Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.

    Shelton RC, Hollon SD, Wisniewski SR, Alpert JE, Balasubramani GK, Friedman ES, Rush AJ, Trivedi MH, Preskorn SH.

    CNS Spectr. 2009 Sep;14(9):487-98.

    PMID:
    19890231
    [PubMed - indexed for MEDLINE]
    15.

    Pattern of depressive symptoms in Parkinson's disease.

    Farabaugh AH, Locascio JJ, Yap L, Weintraub D, McDonald WM, Agoston M, Alpert JE, Growdon J, Fava M.

    Psychosomatics. 2009 Sep-Oct;50(5):448-54. doi: 10.1176/appi.psy.50.5.448.

    PMID:
    19855029
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.

    Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M.

    J Clin Psychiatry. 2009 Dec;70(12):1636-44. doi: 10.4088/JCP.08m04603. Epub 2009 Aug 25.

    PMID:
    19709502
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder.

    Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE.

    J Clin Psychopharmacol. 2009 Aug;29(4):372-7. doi: 10.1097/JCP.0b013e3181ac4aaf.

    PMID:
    19593178
    [PubMed - indexed for MEDLINE]
    18.

    Frontal EEG predictors of treatment outcome in major depressive disorder.

    Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M.

    Eur Neuropsychopharmacol. 2009 Nov;19(11):772-7. doi: 10.1016/j.euroneuro.2009.06.001. Epub 2009 Jul 1.

    PMID:
    19574030
    [PubMed - indexed for MEDLINE]
    19.

    Obesity among those with mental disorders: a National Institute of Mental Health meeting report.

    Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE.

    Am J Prev Med. 2009 Apr;36(4):341-50. doi: 10.1016/j.amepre.2008.11.020.

    PMID:
    19285199
    [PubMed - indexed for MEDLINE]
    20.

    Toward achieving optimal response: understanding and managing antidepressant side effects.

    Kelly K, Posternak M, Alpert JE.

    Dialogues Clin Neurosci. 2008;10(4):409-18. Review.

    PMID:
    19170398
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk